Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
03/2010
03/30/2010CA2442673C Cactaceae-based formulation having the property of fixing fats, and method for obtaining same
03/30/2010CA2439418C Film coating agent
03/30/2010CA2438651C Mucoadhesive, disintegratable medicinal preparation for active substance administration in veterinary and human medicine
03/30/2010CA2424462C Clavulanic acid pharmaceutical compositions
03/30/2010CA2422859C Implantable drug delivery patch
03/30/2010CA2409665C Novel composition
03/30/2010CA2380673C Compositions comprising modafinil for treatment of attention deficit hyperactivity disorder
03/30/2010CA2380451C Primary composition containing a lipophilic bioactive compound
03/30/2010CA2378855C Titanium derived compounds, preparation and use thereof
03/30/2010CA2362277C Spontaneously dispersible n-benzoyl staurosporine compositions
03/30/2010CA2356404C Method for accelerating the rate of mucociliary clearance
03/30/2010CA2355860C Dosage forms comprising porous particles
03/30/2010CA2263765C Methods for the production of protein particles useful for delivery of pharmacological agents
03/25/2010WO2010034019A1 Transdermal drug delivery using an osmolyte and vasoactive agent
03/25/2010WO2010033954A2 Galenical formulations of organic compounds
03/25/2010WO2010033832A2 Estriol formulations
03/25/2010WO2010033800A2 Tetracycline stabilizing formulations
03/25/2010WO2010033776A1 Microencapsulation process with solvent and salt
03/25/2010WO2010033726A2 Drug delivery composition comprising a self-assembled gelator
03/25/2010WO2010033688A2 Nucleic acids encoding spider glue proteins and methods of use thereof
03/25/2010WO2010033686A1 Methods for improved cryo-chemotherapy tissue ablation
03/25/2010WO2010033611A1 Decomposable biocompatible hydrogels and system and method for using same
03/25/2010WO2010033598A2 System and method for utilizing microbubbles and liposomes as viral sequestering agents
03/25/2010WO2010033581A1 Molecular modulators of the wnt/beta-catenin pathway
03/25/2010WO2010033528A1 Stabilized pharmaceutical sub-micron suspensions and methods of forming same
03/25/2010WO2010033392A2 Methods and kits for treating cluster headache disorders
03/25/2010WO2010033179A1 Granulates, process for preparing them and pharmaceutical products containing them
03/25/2010WO2010033137A1 Polymeric biolubricants for medical use
03/25/2010WO2010033042A1 A process for the preparation of a multi-compartment lipid implant
03/25/2010WO2010033022A1 Method for the preparation of a controlled release system
03/25/2010WO2010032880A2 Prophylactic/therapeutic agent for cancer
03/25/2010WO2010032717A1 Film-coated scored tablet
03/25/2010WO2010032434A1 Composite organic compound powder for medical use, method for producing same and suspension of same
03/25/2010WO2010032408A1 Vaccine preparation for neospora caninum infection
03/25/2010WO2010032220A1 Stable liquid antibody formulation
03/25/2010WO2010032199A1 A stimulatable asymmetrical polymersome
03/25/2010WO2010032170A1 Mri-visible sutures for minimally invasive image-guided anastomosis
03/25/2010WO2010032128A1 Pharmaceutical dosage forms comprising poly(e-caprolactone)
03/25/2010WO2010032113A2 Composition and use of a long-acting oral bioadhesive endoparasiticide gel based on doramectin
03/25/2010WO2010032006A2 Treatment of adrenal insufficiency
03/25/2010WO2010031902A1 An inserter
03/25/2010WO2010031900A1 An inserter
03/25/2010WO2010031899A1 An inserter
03/25/2010WO2010031866A1 Lactose and cellulose-based tableting aid
03/25/2010WO2010031819A1 Treating inflammation and inflammatory pain in mucosa using mucosal prolonged release bioadhesive therapeutic carriers.
03/25/2010WO2010031720A2 Novel antibody formulation
03/25/2010WO2010031552A1 Process for preparing snuff composition
03/25/2010WO2010031536A1 Nicotine-containing granulate
03/25/2010WO2010031532A2 Granulate in particular as a pharmaceutical vehicle for lipophilic medicaments
03/25/2010WO2010031346A1 Freeze-dried preparation of tetrodotoxin and the producing method thereof
03/25/2010WO2010031096A1 Antimicrobially and antivirally acting composition
03/25/2010WO2010013224A3 Curcumin nanoparticles and methods of producing the same
03/25/2010WO2010012940A3 Microparticulate oral drug form useful for the modified release of nanoparticles
03/25/2010WO2010009277A9 Immunogenic amphipathic peptide compositions
03/25/2010WO2010007515A3 System for the colon delivery of drugs subject to enzyme degradation and/or poorly absorbed in the gastrointestinal tract
03/25/2010WO2010006200A3 Triggered release of drugs from polymer particles
03/25/2010WO2010005770A3 Electrostatically charged nasal application multipurpose product and method
03/25/2010WO2010005740A3 Methods for the preparation of targeting agent functionalized diblock copolymers for use in fabrication of therapeutic targeted nanoparticles
03/25/2010WO2010005637A3 Electrostatically charged multi-acting nasal application, product, and method
03/25/2010WO2010002450A3 Micelles for delivery of nitric oxide
03/25/2010WO2009158387A3 Compositions, formulations, and methods for preventing and/or treating physical effects of alcohol consumption
03/25/2010WO2009158256A3 Transdermal delivery apparatus and method
03/25/2010WO2009154396A3 Sustained releasing preparation comprising a crude drug extract for preventing moisturization and controlled release
03/25/2010WO2009152028A3 Pharmaceutical formulations comprising stabilized polysaccharides, source of hydrogen peroxide and anti-oxidants
03/25/2010WO2009149418A3 Compositions for the in vivo delivery of rnai agents
03/25/2010WO2009149288A3 Extracts of cranberry and methods of using thereof
03/25/2010WO2009137592A3 Surface-modified nanoparticles
03/25/2010WO2009127974A3 Pharmaceutical formulation for treating cardiovascular disease
03/25/2010WO2009125432A3 Gas empowered expandable drug delivery systems
03/25/2010WO2009106555A3 Sterilized sucralfate gel
03/25/2010WO2009098404A8 Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof
03/25/2010WO2009090484A3 Mesalazine tablet
03/25/2010WO2009050289A3 Solid dispersion product containing n-aryl urea-based compound
03/25/2010WO2008106366A3 Resin reinforced zinc polycarboxylate temporary cement compositions and related kits and methods
03/25/2010US20100076465 Fibrin-based nerve repair conduit and method of producing the same
03/25/2010US20100076413 Diaphragm drug pump
03/25/2010US20100076400 Method and device for painless injection of medication
03/25/2010US20100076387 Twin Transdermal Drug Delivery Patch
03/25/2010US20100076112 Crosslinkable pressure-sensitive adhesive for skin
03/25/2010US20100076094 Formulation containing phosphate derivatives of electron transfer agents
03/25/2010US20100076084 Method of Treating Metabolic Disorders, Especially Diabetes, or a Disease or Condition Associated with Diabetes
03/25/2010US20100076079 Pharmaceutical Compositions Of Short-Acting Sedative Hypnotic Agent
03/25/2010US20100076067 Biodegradable block copolymeric compositions for drug delivery
03/25/2010US20100076043 Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
03/25/2010US20100076033 Methods For Treating Hyperlipidemia with Intermediate Release Nicotinic Acid Compositions Having Unique Biopharmaceutical Characteristics
03/25/2010US20100076008 Pharmaceutical compositions containing plasma protein
03/25/2010US20100074961 purifying protein-containing-polyethylene glycol-microspheres using a supercritical fluid
03/25/2010US20100074960 High-loading, controlled-release magnesium oral dosage forms and methods of making and using same
03/25/2010US20100074959 Lipid growth factor formulations
03/25/2010US20100074958 Methods and compositions for targeting fenestrated vasculature
03/25/2010US20100074957 Intraocular formulation
03/25/2010US20100074956 Formation of hydrogel in the presence of peroxidase and low concentration of hydrogen peroxide
03/25/2010US20100074955 Combination of NMDA-Receptor Ligand and a Compound With 5-HT6 Receptor Affinity
03/25/2010US20100074954 Adsorbent for oral administration
03/25/2010US20100074953 Methods for intiating in situ formation of hydrogels
03/25/2010US20100074952 Tasted masked veterinary solid compositions
03/25/2010US20100074951 Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors
03/25/2010US20100074950 Anti-diabetic combinations
03/25/2010US20100074949 Pharmaceutical composition and administration thereof
03/25/2010US20100074948 Method of producing fast dissolving tablets
1 ... 932 933 934 935 936 937 938 939 940 941 942 943 944 945 946 947 948 949 950 951 952 ... 2991